These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11000468)

  • 1. Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.
    Wu S; Beier M; Sztein MB; Galen J; Pickett T; Holder AA; Gómez-Duarte OG; Levine MM
    J Biotechnol; 2000 Sep; 83(1-2):125-35. PubMed ID: 11000468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
    Barry EM; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine MM
    Infect Immun; 1996 Oct; 64(10):4172-81. PubMed ID: 8926085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
    Nurul AA; Norazmi MN
    Parasitol Res; 2011 Apr; 108(4):887-97. PubMed ID: 21057812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
    Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
    Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
    Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
    Orr N; Galen JE; Levine MM
    Vaccine; 2001 Feb; 19(13-14):1694-700. PubMed ID: 11166893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.
    Pang AL; Hashimoto CN; Tam LQ; Meng ZQ; Hui GS; Ho WK
    Infect Immun; 2002 Jun; 70(6):2772-9. PubMed ID: 12010962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.
    Uthaipibull C; Aufiero B; Syed SE; Hansen B; Guevara Patiño JA; Angov E; Ling IT; Fegeding K; Morgan WD; Ockenhouse C; Birdsall B; Feeney J; Lyon JA; Holder AA
    J Mol Biol; 2001 Apr; 307(5):1381-94. PubMed ID: 11292349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.
    Mazumdar S; Mukherjee P; Yazdani SS; Jain SK; Mohmmed A; Chauhan VS
    Infect Immun; 2010 Feb; 78(2):872-83. PubMed ID: 19933832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production.
    Qian F; Pan W
    Infect Immun; 2002 Apr; 70(4):2029-38. PubMed ID: 11895968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
    Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1.
    Parra M; Hui G; Johnson AH; Berzofsky JA; Roberts T; Quakyi IA; Taylor DW
    Infect Immun; 2000 May; 68(5):2685-91. PubMed ID: 10768960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain.
    Gómez-Duarte OG; Galen J; Chatfield SN; Rappuoli R; Eidels L; Levine MM
    Vaccine; 1995 Nov; 13(16):1596-602. PubMed ID: 8578848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification and characterization of allelic variants of MSP-1(42) from Indian Plasmodium falciparum isolates.
    Lalitha PV; Biswas S; Pillai CR; Seth RK; Saxena RK
    Vaccine; 2010 Jun; 28(29):4661-7. PubMed ID: 20452429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
    Capozzo AV; Cuberos L; Levine MM; Pasetti MF
    Infect Immun; 2004 Aug; 72(8):4637-46. PubMed ID: 15271924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
    Pan W; Ravot E; Tolle R; Frank R; Mosbach R; Türbachova I; Bujard H
    Nucleic Acids Res; 1999 Feb; 27(4):1094-103. PubMed ID: 9927744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
    Cheng XJ; Hayasaka H; Watanabe K; Tao YL; Liu JY; Tsukamoto H; Horii T; Tanabe K; Tachibana H
    Infect Immun; 2007 Jul; 75(7):3614-20. PubMed ID: 17452466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
    Burns JM; Flaherty PR; Romero MM; Weidanz WP
    Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum 19 kDa of merozoite surface protein-1 (MSP-1(19)) expressed in Mycobacterium bovis bacille Calmette Guerin (BCG) is reactive with an inhibitory but not a blocking monoclonal antibody.
    Nurul AA; Rapeah S; Norazmi MN
    Trop Biomed; 2010 Apr; 27(1):60-7. PubMed ID: 20562815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.